First Financial Bankshares’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
438,847
+5,263
+1% +$138K 0.2% 68
2026
Q1
$12.2M Buy
433,584
+61,763
+17% +$1.64M 0.25% 66
2025
Q4
$9.26M Sell
371,821
-54,776
-13% -$1.38M 0.19% 65
2025
Q3
$10.9M Buy
426,597
+9,050
+2% +$223K 0.22% 63
2025
Q2
$10.1M Buy
417,547
+1,377
+0.3% +$32.1K 0.23% 66
2025
Q1
$10.5M Buy
416,170
+18,696
+5% +$489K 0.23% 66
2024
Q4
$10.5M Sell
397,474
-14,695
-4% -$399K 0.23% 65
2024
Q3
$11.9M Buy
412,169
+1,334
+0.3% +$38.9K 0.25% 64
2024
Q2
$11.5M Buy
410,835
+4,824
+1% +$133K 0.26% 64
2024
Q1
$11.3M Buy
406,011
+96,818
+31% +$2.69M 0.25% 65
2023
Q4
$8.9M Buy
+309,193
New +$9.35M 0.21% 69

Other funds holding PFE

First Financial Bankshares's PFE Position: Q2 2026 in Review

First Financial Bankshares increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $138K and bringing the position to 438,847 shares worth $10.6M. The position accounts for 0.2% of the portfolio, ranked #68.

First Financial Bankshares first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.2M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • First Financial Bankshares held 438,847 shares of Pfizer worth $10.6M as of Q2 2026.
  • First Financial Bankshares bought 5,263 Pfizer shares in Q2 2026, an estimated $138K.
  • Pfizer made up 0.2% of First Financial Bankshares's portfolio in Q2 2026, its #68 holding.
  • First Financial Bankshares first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • First Financial Bankshares's Pfizer position peaked at $12.2M in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First Financial Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.